Modulation of arsenic-induced epidermal growth factor receptor pathway signalling by resveratrol

Chemico-Biological Interactions

Volumn 198, Issue 1-3, 2012, Pages 38-48

  Herbert, Katharine J ^a   Snow, Elizabeth T ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Arsenite; DNA polymerase beta; Epidermal growth factor; Extracellular signal regulated kinases 1 and 2; Heme oxygenase 1; Resveratrol

Indexed keywords

ARSENIC TRIOXIDE; BIOLOGICAL MARKER; CELL PROTEIN; CSRC PROTEIN; DNA DIRECTED DNA POLYMERASE BETA; EPIDERMAL GROWTH FACTOR RECEPTOR; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAC1 PROTEIN; RAS PROTEIN; RESVERATROL; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INDUCTION; EXCISION REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KERATINOCYTE; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ARSENIC; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STILBENES;

VITACEAE;

EID: 84862175656     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.05.004     Document Type: Article

References (71)

1. T. Agusa, H. Iwata, J. Fujihara, T. Kunito, H. Takeshita, T.B. Minh, P.T. Trang, P.H. Viet, and S. Tanabe Genetic polymorphisms in glutathione S-transferase (GST) superfamily and arsenic metabolism in residents of the Red River Delta Vietnam Toxicol. Appl. Pharmacol. 242 2010 352 362
2. L. Almeida, M. Vaz-da-Silva, A. Falcao, E. Soares, R. Costa, A.I. Loureiro, C. Fernandes-Lopes, J.F. Rocha, T. Nunes, L. Wright, and P. Soares-da-Silva Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers Mol. Nutr. Food Res. 53 Suppl 1 2009 S7 S15
3. M. Athar, J.H. Back, L. Kopelovich, D.R. Bickers, and A.L. Kim Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms Arch. Biochem. Biophys. 486 2009 95 102
4. N. Azios, L. Krishnamoorthy, M. Harris, L. Cubano, M. Cammer, and S. Dharmawardhane Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells Neoplasia 9 2007 147 158
5. J.R. Bacon, G. Williamson, R.C. Garner, G. Lappin, S. Langouet, and Y. Bao Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes Carcinogenesis 24 2003 1903 1911 (Pubitemid 38008530)
6. K. Bedard, and K.-H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol. Rev. 87 2007 245 313 (Pubitemid 46209993)
7. A.M. Bode, and Z. Dong The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects Crit. Rev. Oncol. Hematol. 42 2002 5 24 (Pubitemid 34229146)
8. c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated Biochemistry 35 1996 9519 9525 (Pubitemid 26320059)
9. D.J. Boocock, G.E. Faust, K.R. Patel, A.M. Schinas, V.A. Brown, M.P. Ducharme, T.D. Booth, J.A. Crowell, M. Perloff, A.J. Gescher, W.P. Steward, and D.E. Brenner Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol. Biomarkers Prev. 16 2007 1246 1252 (Pubitemid 46984966)
10. T. Boutros, E. Chevet, and P. Metrakos Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer Pharmacol. Rev. 60 2008 261 310
11. K. Briviba, L. Pan, and G. Rechkemmer Red wine polyphenols inhibit the growth of colon carcinoma cells and modulate the activation pattern of mitogen-activated protein kinases J. Nutr. 132 2002 2814 2818 (Pubitemid 35013276)
12. J. Centeno, F. Mullick, L. Martinez, N. Page, H. Gibb, D. Longfellow, C. Thompson, and E. Ladich Pathology related to chronic arsenic exposure Environ. Health Perspect. 110 2002 883 886 (Pubitemid 35276887)
13. W. Chen, J. Martindale, N. Holbrook, and Y. Liu Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc Mol. Cell. Biol. 18 1998 5178 5188 (Pubitemid 28388101)
14. G. Cheng, B. Diebold, Y. Hughes, and J. Lambeth Nox1-dependent reactive oxygen generation is regulated by Rac1 J. Biol. Chem. 281 2006 17718 17726 (Pubitemid 44035570)
15. C. de la Lastra, and I. Villegas Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications Biochem. Soc. Trans. 35 2007 1156 1160 (Pubitemid 350206449)
16. A.S. Dhillon, S. Hagan, O. Rath, and W. Kolch MAP kinase signalling pathways in cancer Oncogene 26 2007 3279 3290 (Pubitemid 46763021)
17. D. Douer, W. Hu, S. Giralt, M. Lill, and J. DiPersio Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation Oncologist 8 2003 132 140 (Pubitemid 36428279)
18. Y. Doza, C. Hall-Jackson, and P. Cohen Arsenite blocks growth factor induced activation of the MAP kinase cascade, upstream of Ras and downstream of Grb2-Sos Oncogene 17 1998 19 24 (Pubitemid 28360525)
19. R. Dworakowski, N. Anilkumar, M. Zhang, and A. Shah Redox signalling involving NADPH oxidase-derived reactive oxygen species Biochem. Soc. Trans. 34 2006 960 964 (Pubitemid 44796460)
20. M. Ebisuya, K. Kondoh, and E. Nishida The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity J. Cell Sci. 118 2005 2997 3002 (Pubitemid 41149904)
21. A. Federico, F. Morgillo, C. Tuccillo, F. Ciardiello, and C. Loguercio Chronic inflammation and oxidative stress in human carcinogenesis Int. J. Cancer 121 2007 2381 2386 (Pubitemid 350022406)
22. G. Filomeni, I. Graziani, G. Rotilio, and M. Ciriolo Trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways Genes Nutr. 2 2007 295 305
23. D. Gianni, B. Bohl, S. Courtneidge, and G. Bokoch The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1 Mol. Biol. Cell 19 2008 2984 2994
24. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70 (Pubitemid 30046295)
25. B.-J. Hwang, C. Utti, and M. Steinberg Induction of cyclin D1 by submicromolar concentration of arsenite in human epidermal keratinocytes Toxicol. Appl. Pharmacol. 217 2006 161 167 (Pubitemid 44711967)
26. S. Kapaj, H. Peterson, K. Liber, and P. Bhattacharya Human health effects from chronic arsenic poisoning - a review J. Environ. Sci. Health. Part A Tox. Hazard. Subst. Environ. Eng. 41 2006 2399 2428 (Pubitemid 44504129)
27. P. Kedar, S. Widen, E. Englander, A. Fornace, and S. Wilson The ATF/CREB transcription factor-binding site in the polymerase β promoter mediates the positive effect of N-methyl-N′-nitro-N-nitrosoguanidine on transcription Proc. Nat. Acad. Sci. U.S.A. 88 1991 3729 3733 (Pubitemid 21916697)
28. A. Keim, T. Rothhaar, O. Rossler, and G. Thiel Arsenite induces oxidative stress and caspase 3-mediated apoptosis in human neuroblastoma cells involving p53 Cell. Commun. Signal. 7 2009 A20
29. J. Klaunig, and L. Kamendulis The role of oxidative stress in carcinogenesis Annu. Rev. Pharmacol. Toxicol. 44 2004 239 267 (Pubitemid 38263841)
30. A. Kotha, M. Sekharam, L. Cilenti, K. Siddiquee, A. Khaled, A. Zervos, B. Carter, J. Turkson, and R. Jove Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein Mol. Cancer Ther. 5 2006 621 629
31. Y. Kumagai, and D. Sumi Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity Annu. Rev. Pharmacol. Toxicol. 47 2007 243 262
32. A. Lemarie, E. Bourdonnay, C. Morzadec, O. Fardel, and L. Vernher Inorganic arsenic activates reduced NADPH oxidase in human primary macrophages through a Rho kinase/p38 kinase pathway J. Immunol. 180 2008 6010 6017
33. A.-L. Lindberg, M. Rahman, L. Persson, and M. Vahter The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure Toxicol. Appl. Pharmacol. 230 2008 9 16
34. S. Ludwig, A. Hoffmeyer, M. Goebeler, K. Kilian, H. Hafner, B. Neufeld, J. Han, and U.R. Rapp The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway J. Biol. Chem. 273 1998 1917 1922 (Pubitemid 28069234)
35. J. Mahata, P. Ghosh, N. Sarkar, K. Ray, A. Natarajan, and A. Giri Effect of sodium arsenite on peripheral lymphocytes in vitro: individual susceptibility among a population exposed to arsenic through the drinking water Mutagenesis 19 2004 223 229 (Pubitemid 38744831)
36. V.D. Martinez, D.D. Becker-Santos, E.A. Vucic, S. Lam, and W.L. Lam Induction of human squamous cell-type carcinomas by arsenic Journal of skin cancer 2011 2011 454157
37. S. Maynard, S. Schurman, C. Harboe, N. de Souza-Pinto, and V. Bohr Base excision repair of oxidative DNA damage and association with cancer and aging Carcinogenesis 30 2009 2 10
38. K. Miyano, N. Ueno, R. Takeya, and H. Sumimoto Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1 J. Biol. Chem. 281 2006 21857 21868
39. S. Nair, W. Li, and A.-N. Kong Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells Acta Pharmacol. Sin. 28 2007 459 472 (Pubitemid 46496089)
40. K. Nohara, K. Ao, Y. Miyamoto, T. Suzuki, S. Imaizumi, Y. Tateishi, S. Omura, C. Tohyama, and T. Kobayashi Arsenite-induced thymus atrophy is mediated by cell cycle arrest: a characteristic downregulation of E2F-related genes revealed by a microarray approach Toxicol. Sci. 101 2008 226 238
41. T. Ochi, K. Kita, T. Suzuki, A. Rumpler, W. Goessler, and K.A. Francesconi Cytotoxic, genotoxic and cell-cycle disruptive effects of thio-dimethylarsinate in cultured human cells and the role of glutathione Toxicol. Appl. Pharmacol. 228 2008 59 67
42. S. Pellegrin, and H. Mellor Rho GTPase activation assays Curr. Protoc. Cell Biol. 38 2008 14.18.11 14.18.19
43. T. Prestera, P. Talalay, J. Alam, Y. Ahn, P. Lee, and A. Choi Parallel induction of heme oxygenase-1 and chemoprotective Phase 2 enzymes by electrophiles and antioxidants: regulation by upstream Antioxidant-Responsive Elements (ARE) Mol. Med. 1 1995 827 837 (Pubitemid 3013090)
44. Y. Qian, V. Castranova, and X. Shi New perspectives in arsenic-induced cell signal transduction J. Inorg. Biochem. 96 2003 271 278 (Pubitemid 36900365)
45. M. Raman, W. Chen, and M.H. Cobb Differential regulation and properties of MAPKs Oncogene 26 2007 3100 3112 (Pubitemid 46763006)
46. R. Ratnaike Acute and chronic arsenic toxicity Postgrad. Med. J. 79 2003 391 396 (Pubitemid 36993968)
47. M. Rea, J. Gregg, Q. Qin, M. Phillips, and R. Rice Global alteration of gene expression in human keratinocytes by inorganic arsenic Carcinogenesis 24 2003 747 756 (Pubitemid 36592410)
48. H. Sauer, M. Wartenberg, and J. Hescheler Reactive oxygen species as intracellular messengers during cell growth and differentiation Cell. Physiol. Biochem. 11 2001 173 186 (Pubitemid 32786086)
49. R. Seger, and E.G. Krebs The MAPK signaling cascade FASEB J. 9 1995 726 735
50. B. Sen, and F.M. Johnson Regulation of SRC family kinases in human cancers J. Signal Transduct. 2011 2011 865819
51. Q.-B. She, A. Bode, W.-Y. Ma, N.-Y. Chen, and Z. Dong Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase Cancer Res. 61 2001 1604 1610 (Pubitemid 34292594)
52. 2-terminal kinases in resveratrol-induced activation of p53 and apoptosis Mol. Carcinog. 33 2002 244 250 (Pubitemid 34297132)
53. P. Simenonova, and M. Luster Arsenic carcinogenicity: relevance of c-Src activation Mol. Cell. Biochem. 234 235 2002 227 282
54. P. Simenonova, S. Wang, T. Hulderman, and M. Luster C-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic J. Biol. Chem. 277 2002 2945 2950 (Pubitemid 34953329)
55. E. Snow, P. Sykora, T. Durham, and C. Klein Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk? Toxicol. Appl. Pharmacol. 207 2005 S557 S564
56. K. Souza, D.A. Maddock, Q. Zhang, J. Chen, C. Chiu, S. Mehta, and Y. Wan Arsenite activation of P13K/AKT cell survival pathway is mediated by p38 in cultured human keratinocytes Mol. Med. 7 2001 767 772 (Pubitemid 34175298)
57. M. Stefani, M. Markus, R. Lin, M. Pinese, I. Dawes, and B. Morris The effect of resveratrol on a cell model of human aging Ann. N. Y. Acad. Sci. 1114 2007 407 418 (Pubitemid 350070370)
58. J. Stewart, and C. O'Brian Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKCα inhibition Invest. New Drugs 22 2004 107 117 (Pubitemid 38270466)
59. J.M. Summy, and G.E. Gallick Src family kinases in tumor progression and metastasis Cancer Metastasis Rev. 22 2003 337 358 (Pubitemid 36791891)
60. P. Sykora, and E. Snow Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite Toxicol. Appl. Pharmacol. 228 2008 385 394
61. T. Tanaka-Kagawa, N. Hanioka, H. Yoshida, H. Jinno, and M. Ando Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes Br. J. Dermatol. 149 2003 1116 1127 (Pubitemid 38058087)
62. D. Thomas Unraveling arsenic-glutathione connections Toxicol. Sci. 107 2009 309 311
63. S. Toyokuni, K. Okamoto, J. Yodoi, and H. Hiai Persistent oxidative stress in cancer FEBS Lett. 358 1995 1 3
64. A. Tyagi, R. Agarwal, and C. Agarwal Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis Oncogene 22 2003 1302 1316 (Pubitemid 36384591)
65. A. Verma, M. Mohindru, D. Deb, A. Sassano, S. Kambhampati, F. Ravandri, S. Minucci, D. Kalvakolanu, and L. Platanias Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide J. Biol. Chem. 277 2002 44988 44995 (Pubitemid 36159097)
66. T. Walle Bioavailability of resveratrol Ann. N. Y. Acad. Sci. 1215 2011 9 15
67. W. Wang, S. Wang, A.F. Howie, G.J. Beckett, R. Mithen, and Y. Bao Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells J. Agric. Food Chem. 53 2005 1417 1421 (Pubitemid 40322128)
68. G.T. Wondrak Redox-directed cancer therapeutics: molecular mechanisms and opportunities Antioxid. Redox Signal. 11 2009 3013 3069
69. M.M. Wu, H.Y. Chiou, T.W. Wang, Y.M. Hsueh, I.H. Wang, C.J. Chen, and T.C. Lee Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan Environ. Health Perspect. 109 2001 1011 1017
70. J.Y. Zhang, T. Ohta, A. Maruyama, T. Hosoya, K. Nishikawa, J.A. Maher, S. Shibahara, K. Itoh, and M. Yamamoto BRG1 interacts with Nrf2 to selectively mediate HO-1 induction in response to oxidative stress Mol. Cell. Biol. 26 2006 7942 7952 (Pubitemid 44630994)
71. G.B. Zhou, J. Zhang, Z.Y. Wang, S.J. Chen, and Z. Chen Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy Philos. Trans. R. Soc. Lond. B Biol. Sci. 362 2007 959 971 (Pubitemid 47056795)